Back
Cartesian Therapeutics Vs. Aritzia Industry Stock Comparison
Buy
70
RNAC
Cartesian Therapeutics
Last Price:
16.97
Seasonality Move:
10.73%
Sell
40
ATZAF
Aritzia
Last Price:
33.13
Seasonality Move:
14.48%
Buy
70
Cartesian Therapeutics (RNAC)
is a Buy
Is Cartesian Therapeutics a Buy, Sell or Hold?
- The current Cartesian Therapeutics [RNAC] share price is $16.93. The Score for RNAC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- RNAC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Aritzia (ATZAF)
is a Sell
Is Aritzia a Buy, Sell or Hold?
- The current Aritzia [ATZAF] share price is $32.80. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNAC Stock Price Chart
What is Cartesian Therapeutics's stock price today?
-
The Cartesian Therapeutics share price today is $16.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing selling pressure, which indicates risk of future bearish movement.
RNAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 36.61 | Sell |
| Chaikin Money Flow: | -65513 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.69 - 22.61) | Sell |
| Bollinger Bands (100): | (14.24 - 21.44) | Sell |
ATZAF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.9 | Sell |
| Relative Strength Index (14 RSI): | 50.73 | Buy |
| Chaikin Money Flow: | 7616 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.43 - 34.95) | Buy |
| Bollinger Bands (100): | (30.1 - 35.52) | Sell |
RNAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.7 | Sell |
| 20-day SMA: | 20.89 | Sell |
| 50-day SMA: | 18.85 | Sell |
| 200-day SMA: | 20.13 | Sell |
| 8-day EMA: | 19.63 | Sell |
| 20-day EMA: | 20.21 | Sell |
| 50-day EMA: | 19.47 | Sell |
| 200-day EMA: | 21.23 | Sell |
ATZAF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.79 | Buy |
| 20-day SMA: | 31.82 | Buy |
| 50-day SMA: | 34.06 | Sell |
| 200-day SMA: | 29.5 | Buy |
| 8-day EMA: | 31.34 | Buy |
| 20-day EMA: | 32.22 | Buy |
| 50-day EMA: | 33.01 | Sell |
| 200-day EMA: | 29.97 | Buy |
Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.
Aritzia Earnings Growth & ATZAF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.
Cartesian Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aritzia Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||